LexisNexis will be offering a webinar on “The Next Billion-Dollar Acquisition in Pharma — A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene” on February 11, 2019 at 2:00 pm (ET). Gene Quinn of IPWatchdog and Kevin Noonan of Patent Docs will take a look at the recently announced merger between Bristol-Myers Squibb and Celgene, including what the combined company will look like from a patent perspective, and what competition regulators are likely to be interested in questioning about this acquisition. Those interested in registering for the webinar, can do so here.
View the original article here: Webinar on the Next Billion-Dollar Acquisition in Pharma
The article was originally posted on Patent Docs.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.